Aeromics, Inc.   Report issue

For profit Phase 1
Founded: Cleveland OH United States (2006)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2018
NCT03804476
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Aeromics, Inc.